Skip to main content

Table 6 Treatment and outcome - Entities mainly prevalent in infants (A)

From: Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany

Patient No. Mechanical ventilation Surfactant treatment, response O2 supply at rest Immuno-suppressive treatment Response to treatment Long term out-come**
1 Yes* yes; good 1 l/min Systemic steroids good but transient died
2 Yes* n.k. n.k. Systemic steroids; Azathioprin; Hydroxychloroquin good;
good;
good
n.k.
3 Yes* yes, good 100% Systemic steroids none died
4 Yes* yes, good 30-100% Systemic steroids; Chloroquin good;
none
died
5 Yes n.k. 2 l/min Systemic steroids; Hydroxychloroquin none;
none
died
6 No n.k. 2 l/min Systemic steroids n.k. alive
7 No n.k. no Systemic steroids good n.k.
8 n.k. n.k. 4 l/min Systemic steroids n.k. alive
9 Yes* yes, none 80-100% Systemic steroids n.k. died
10 Yes* yes, none transient Systemic steroids good alive
11 Yes* yes, good 1 l/min Systemic steroids good but transient alive
12 Yes* yes, good transient No steroids   alive
13 No n.k. n.k. n.k.   n.k.
14 Yes* yes, none transient No steroids   alive
15 No* no 1-2 l/min Systemic steroids good n.k.
16 No no n.k. n.k.   n.k.
17 No* n.k.   n.k.   n.k.
18 Yes* n.k.   n.k.   n.k.
19 No no 0,7-2 l/min Systemic steroids n.k. alive
20 Yes no 1 l/min No steroids   alive
21 No n.k. 2 l/min Systemic steroids good alive
  1. * Initial symptoms within the neonatal period; ** Follow up information was obtained one year after inclusion of the subject into the survey
  2. n.k., not known;